Monell Chemical Senses Center biopsychologist Julie A. Mennella, PhD, has been recognized by the Association for Chemoreception Sciences with the 2020 Max Mozell Award for Outstanding Achievement in the Chemical Senses and will present a lecture at its virtual annual meeting on 22 April 2021....
PHILADELPHIA, January 18, 2021 - According to the Centers for Disease Control, nearly three million people will acquire an antibiotic-resistant infection each year in the United States. Doctors are currently overprescribing antibiotics for feverish individuals during the pandemic, despite widespread knowledge that COVID-19 is caused...
PHILADELPHIA, December 28, 2020 – A Monell Chemical Senses Center and Temple University team recently became part of a new, multi-institute National Institute of Health (NIH)-funded initiative called the Rapid Acceleration of Diagnostic Radical program (RADx). The NIH invested $107 million at 43 institutions across...
New Kare research fellow Yali Zhang, PhD studies how animals sense their complex food environment, including food taste and texture....
Research led by Monell finds direct methods vs, self-report show 75% of people with COVID-19 lose their sense of smell....
New research, led by the Monell Chemical Senses Center, has now found that liking of fatty food is more complex than its fat content alone – it could also be related to inborn genetic traits of the consumer related to fat perception....
Amber Alhadeff, PhD, the newest faculty member at the Monell Chemical Senses Center, has been awarded a 2020 Klingenstein-Simons Fellowship Award in Neurosciences, totaling $225,000 over three years....
Smell and taste loss are useful predictors of COVID-19, but it can be difficult to become aware of changes in these senses. With the smell-and-taste-check tool from the Global Consortium for Chemosensory Researchers (GCCR), people can track the acuity of their senses of smell and...
In a continuation of their industry-academic partnership, DiscoveryBioMed and the Monell Center have been awarded nearly $1.7 million over the next two years by the National Institutes of Health’s Small Business Technology Transfer Research program to find bitter taste blockers to improve medication compliance. ...
Following a wave of reports from patients and clinicians about rapid onset smell loss, health organizations throughout the world have recognized anosmia, and possibly ageusia, are potential markers for COVID-19, even in the absence of other symptoms....